Oral Wegovy (50 mg daily) was approved December 2025 at $149/month intro pricing with 16.6% weight loss at 64 weeks
The injection of semaglutide also slows the movement of food through the stomach, which may lead to weight loss and a decrease in appetite
Tirzepatide Mounjaro 15mg x 1 vial Tirzepatide Mounjaro 2.5 mg, 5 mg, 7.5 mg, 10 mg, 12.5 mg, and 15 mg per 0.5 mL injection, is a prescription medicine for adults with type 2 diabetes used along with diet and exercise to improve blood sugar (glucose)
6.2 Postmarketing Experience The following adverse reactions have been reported during post-approval use of semaglutide, the active ingredient of OZEMPIC
Website External link for Trava Health Industry Retail Health and Personal Care Products Company size 11-50 employees Headquarters Houston, Texas Type Public Company Founded 2024 Locations Primary Get directions 21175 TX-249 #239 Houston, Texas 77070, US Employees at Trava Health Updates Hi everyone, we are closing our job postings on LinkedIn